About Candel Therapeutics, Inc. 
Candel Therapeutics, Inc.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 20 Schemes (27.07%)
Foreign Institutions
Held by 22 Foreign Institutions (2.33%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
Miscellaneous
USD 280 Million ()
NA (Loss Making)
NA
0.00%
-1.02
-39.06%
3.10






